Yüklüyor......
Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?
BACKGROUND: Tafenoquine (TQ) was recently approved by the US Food and Drug Administration for prophylaxis of malaria and, in addition, for eradication of the hepatic phase of the relevant Plasmodium species. In this study, we evaluated the efficacy of TQ for treatment of Babesia microti infection in...
Kaydedildi:
| Yayımlandı: | J Infect Dis |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6603973/ https://ncbi.nlm.nih.gov/pubmed/31099380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz119 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|